The post The September 2025 <em>News from ECOG-ACRIN</em> blog is now available appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post WATCH: Dr. David Gerber discusses E4512 ALCHEMIST trial data at <em>World Conference on Lung Cancer</em> appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
The post EA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
Research results from our work area on EU-China cooperation in science, technology and innovation were presented in two conferences in Germany before the summer. Philipp Brugner from our partner ZSI delivered these presentations, drawing on the work done with his colleague Gábor Szüdi in their trans-European survey on research security in the cooperation with China, which was implemented on behalf of the ReConnect China project between May 2024 and January 2025.| Reconnect China
The post The August 2025 <em>News from ECOG-ACRIN</em> blog is now available appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
On May 20, the Central European Institute of Asian Studies (CEIAS) and the University of Notre Dame’s Keough School of Global Affairs, in collaboration with Palacký University Olomouc (ReConnect China partner) and with support of two of the three China cluster projects (‘EuroHub4China’ and ‘Reconnect China’) organised a high-level policy workshop in Prague. The workshop […]| Reconnect China
